Dai Yong is the founder of Frontera Therapeutics. Frontera Therapeutics has raised $195M in total funding. Latest round: Series B.
Yong Dai, Ph.D., is a co-founder and CEO of Frontera Therapeutics, a clinical-stage biotechnology company that develops gene therapy medicines across multiple disease areas. The company has secured $195 million in total venture funding since its founding in 2019. Prior to Frontera, Dai led Prevail Therapeutics to a successful Nasdaq listing and acquisition by Eli Lilly.
Full founder directory · Investor directory · Company funding database · Fundraising library